El Salvador a model in drug regulation for the Central American region.
The National Director of Drugs, Dr. Leonor Morales de Acosta presented the report of accountability for the period from June 2017 to May 2018, in which she highlights important achievements.
Dr. de Acosta, highlighted that now El Salvador has a market of quality medicines and fair prices, also reported that the market has been revitalized with the registration of more than 6 thousand new medicines which guarantees the supply and availability of more therapeutic options for patients.
“Another achieved unprecedented for the Central American region has been the regulation of retail prices, El Salvador now has the lowest prices in the region, consequently the population has saved a significant amount of money, in these 6 years saving in the pocket has been about 500 million dollars, “said the head of the DNM.
For more information https://www.medicamentos.gob.sv/index.php/es/secciones-m/noticias-dnm/291-memoria-de-labores-2018